b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="In-Process" Owner="NLM">\n        <PMID Version="1">32247288</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>07</Month>\n            <Day>21</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1610-0387</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>18</Volume>\n                    <Issue>4</Issue>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>Apr</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG</Title>\n                <ISOAbbreviation>J Dtsch Dermatol Ges</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Compounded preparations in dermatology - analysis of prescribing habits in everyday clinical practice in Germany.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>334-340</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1111/ddg.14071</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Compounded preparations (CPs) are an indispensable addition to approved, commercially available drugs (CADs), especially for topical therapy. In Germany, about eight million CPs are prescribed within the statutory health insurance system each year, 50\xc2\xa0% thereof by dermatologists.</AbstractText>\n                <AbstractText Label="METHODS" NlmCategory="METHODS">We analyzed prescribing habits based on a questionnaire sent out to 186 office-based dermatologists and 1,491 pharmacies in the federal states of Rhineland-Palatinate and Saarland. The goal was to improve patient care by collecting and categorizing data in terms of prescription practice and associated challenges in interdisciplinary cooperation.</AbstractText>\n                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, 351 pharmacists (23.5\xc2\xa0%) and 53 dermatologists (28.4\xc2\xa0%) participated in this survey. The most common reason (83\xc2\xa0%) stated for prescribing a CP was the possibility to prescribe large quantities of a given topical medication; CPs were most commonly prescribed for psoriasis and various types of dermatitis. The most frequently prescribed active pharmaceutical ingredients were triamcinolone (80\xc2\xa0%), erythromycin (78.3\xc2\xa0%) and clotrimazole (72.5\xc2\xa0%). Fifty-eight percent of pharmacists reported that the collaboration with dermatologists was &quot;associated with problems&quot;; 34\xc2\xa0% complained about insufficient communication.</AbstractText>\n                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">CPs are essential for optimizing patient care. Interdisciplinary cooperation poses a challenge to both physicians and pharmacists. In this context, it is important to increase collaborative efforts in terms of training and continuing medical education. Further studies on CPs are required to better elucidate the challenges and opportunities associated with their prescription.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2020 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley &amp; Sons Ltd.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Salzmann</LastName>\n                    <ForeName>Stefan</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, University Medical Center, M\xc3\xbcnster, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Salzmann</LastName>\n                    <ForeName>Martin</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, University Medical Center, Heidelberg, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Staubach</LastName>\n                    <ForeName>Petra</ForeName>\n                    <Initials>P</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Dermatology, University Medical Center, Mainz, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2020</Year>\n                <Month>04</Month>\n                <Day>04</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Germany</Country>\n            <MedlineTA>J Dtsch Dermatol Ges</MedlineTA>\n            <NlmUniqueID>101164708</NlmUniqueID>\n            <ISSNLinking>1610-0379</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>09</Month>\n                <Day>08</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>02</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2020</Year>\n                <Month>4</Month>\n                <Day>5</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>4</Month>\n                <Day>5</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2020</Year>\n                <Month>4</Month>\n                <Day>5</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">32247288</ArticleId>\n            <ArticleId IdType="doi">10.1111/ddg.14071</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Title>References</Title>\n            <Reference>\n                <Citation>Staubach P, Salzmann S, Peveling-Oberhag A et\xc2\xa0al. Extemporaneous formulations in Germany - relevance for everyday clinical practice. J Dtsch Dermatol Ges 2018; 16: 566-74.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Altmeyer P, Bergmeyer V, Wienand W. Analysis of compound prescriptions by practicing dermatologists. A study of 72,615 prescriptions for patients insured by the North Rhine-Westphalia BKK. Hautarzt 1997; 48: 12-20.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Ewering I. Prescriptions: how does the pharmacy check for plausibility? Hautarzt 2015; 66: 967-70.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>DAC/NRF Pharmazeutisches Laboratorium des. Standardisierte Rezepturen Formelsammlung f\xc3\xbcr \xc3\x84rzte. 9th Edition. Govi-Verlag, Eschborn, 2017.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Augustin M, Gass S, Merk H et\xc2\xa0al. Leitfaden zur Verordnung von Arzneimitteln in der vertrag\xc3\xa4rztlichen dermatologischen Therapie. 2012.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Rote Liste 2017: Arzneimittelverzeichnis f\xc3\xbcr Deutschland (einschlie\xc3\x9flich EU-Zulassungen und bestimmter Medizinprodukte). Rote Liste Service GmbH (Verlag), Frankfurt, 2017.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Augustin M, Herberger K, Hintzen S et\xc2\xa0al. Prevalence of skin lesions and need for treatment in a cohort of 90 880 workers. Br J Dermatol 2011; 165: 865-73.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Augustin M, Reich K, Glaeske G et\xc2\xa0al. Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany. Acta Derm Venereol 2010; 90: 147-51.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Nevitt GJ, Hutchinson PE. Psoriasis in the community: prevalence, severity and patients\xe2\x80\x99 beliefs and attitudes towards the disease. Br J Dermatol 1996; 135: 533-7.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Broberg A, Svensson A, Borres MP, Berg R. Atopic dermatitis in 5-6-year-old Swedish children: cumulative incidence, point prevalence, and severity scoring. Allergy 2000; 55: 1025-9.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Staubach P. Sense and nonsense of extemporaneous formulations. Hautarzt 2014; 65: 180-5.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wollenberg A, Barbarot S, Bieber T et\xc2\xa0al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol 2018; 32: 850-78.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Hoffmann C. Officinal bases and their characteristics. Hautarzt 2016; 67: 190-2.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wollenberg A, Bieber T, Dirschka T et\xc2\xa0al. Perioral dermatitis. J Dtsch Dermatol Ges 2011; 9: 422-7.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Danninger L. Magistrale Rezepturen - Aus der Praxis F\xc3\xbcr die Praxis. AV Akademikerverlag, Saarbr\xc3\xbccken, 2014.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Melhorn S. Local antibiotics or antiseptics in combination with glucocorticoids. Hautarzt 2016; 67: 850-2.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wohlrab J. Individualized drug compounding. J Dtsch Dermatol Ges 2013; 11: 1035-6.</Citation>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'